Stocks / NASDAQ / Madrigal Pharmaceuticals, Inc.

Madrigal Pharmaceuticals, Inc.

Our Opinion

Madrigal Pharmaceuticals, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“In animal models of liver fibrosis, the extent of fibrosis is decreased by Thyroid Hormone administration and increased if Thyroid Hormone Receptor is knocked out.” (Page 10) Read the following document

Company Description

Madrigal Pharmaceuticals, Inc. clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel compounds for the treatment of cardiovascular, metabolic and liver diseases. The company offers MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Madrigal Pharmaceuticals was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA. [Source: MarketWatch]

Company Website: